Laboratory investigations showed mild renal impairment, an elevated HbA1c indicating poor glycemic control, and an increased level of neuron-specific enolase (NSE), a marker often elevated in neuroendocrine tumors. The gene discussed is ENO2; the disease is neuroendocrine neoplasm.